Pathway Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-190,286	Closed	-$5.62M	–	14
2023 Q4	$5.62M	Buy	+190,286	New	+$5.62M	6.28%	6
2023 Q3	–	Sell	-24,784	Closed	-$641K	–	12
2023 Q2	$641K	Buy	+24,784	New	+$641K	1.15%	9